MSME

Generic medicines in India face scrutiny as the CDSCO grapples with substandard drugs, lack of human resources, state data blackouts, and MSME violations.

Launched in 2014 to transform India into a global manufacturing hub, the Make in India initiative captured the nation's imagination as a bold and ambitious plan to stimulate economic growth, boost job creation, and attract foreign investments. Now, nearly a decade since its inception, the time has come to evaluate whether the Make in India initiative has fulfilled its promise and met its expectations.